REVIEWING THE MEDISAVE SCHEME FOR OVERSEAS ELECTIVE TREATMENTS
9 September 2026
NOTICE PAPER NO. 1197
NOTICE OF QUESTION FOR ORAL ANSWER
FOR THE SITTING OF PARLIAMENT ON OR AFTER 09 SEPTEMBER 2026
Name and Constituency of Member of Parliament
Dr Hamid Razak
MP for West Coast-Jurong West GRC
Question No. 2738
Dr Hamid Razak: To ask the Coordinating Minister for Social Policies and Minister for Health (a) what are the accreditation criteria for overseas hospitals under the MediSave scheme; (b) how frequently are these criteria reviewed; and (c) whether the Ministry will assess if increased patient flow via the Johor Bahru-Singapore Rapid Transit System (RTS) Link warrants changes to the accreditation framework.
NOTICE PAPER NO. 1297
NOTICE OF QUESTION FOR ORAL ANSWER
FOR THE SITTING OF PARLIAMENT ON OR AFTER 10 SEPTEMBER 2026
Name and Constituency of Member of Parliament
Mr Fadli Fawzi
MP for Aljunied GRC
Question No. 2998
Mr Fadli Fawzi: To ask the Coordinating Minister for Social Policies and Minister for Health (a) whether any new healthcare providers have been added to the list of overseas hospitals participating in the MediSave scheme since 2010; (b) what key lessons has the Ministry learnt since the implementation of the overseas MediSave scheme; (c) whether there are plans to expand the scheme further; and (d) if not, why not.
Answer
1 Mr Speaker, my response will also address a similar question raised by Mr Fadli Fawzi filed for a subsequent sitting. If the MP is satisfied with the response, he may wish to withdraw the question from that sitting.
2 The use of MediSave for overseas elective treatments is intended to give patients wider choice. As part of the extension, participating overseas hospitals must have an approved working arrangement with a MediSave-accredited institution in Singapore. The local centre must refer the patient, provide pre-admission clinical assessment and financial counselling to interested patients. Such partnership applications must be approved by the Ministry of Health (MOH).
3 Since the scheme was introduced in 2010, no new local providers have been accredited and one local provider withdrew from the scheme in 2023. Currently, two Malaysian hospitals, Mahkota Medical Centre and Regency Specialist Hospital, participate through their MediSave-accredited local partner, HMI Medical Centre.
4 MOH has been monitoring the implementation of the scheme. Utilisation has generally remained low at an average of 300 claims per year from 2023 - 2025, mainly for Obstetrics and Gynecology treatments. In view of the expected increase in cross-border patient flow with the Johor Bahru–Singapore RTS Link, MOH is currently reviewing the scheme.
